SCHEMBL7964673

SCHEMBL7964673

O=S(=O)(O)NCc1csc2cncn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7964619 0.86
SCHEMBL7492128 0.85 SETDB1 (0.31)
SCHEMBL7963870 0.65 CHEK1 (0.31)
SCHEMBL7492830 0.63
SCHEMBL5656919 0.56 SMN1; SMN2 (0.58)
SCHEMBL7968349 0.56 TP53 (0.34)
SCHEMBL5652939 0.55 CYP1A2 (0.58)
SCHEMBL5632849 0.54 MEN1 (0.55)
SCHEMBL29287051 0.54 ATM (0.38)
SCHEMBL229506 0.51 CA12 (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242437-B1 HAS HIGHER ANTIMICROBIAL ACTIVITY AGAINST METHICILLINE-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA), PENICILLIN-RESISTANT STREPTOCOCCUS PNEUMONIAE (PRSP), AND IMIPENEM-RESISTANT PSEUDOMONAS AERUGINOSA ONIUM SALT MEIJI SEIKA KAISHA, LTD. (JP) 2001-06-05 US disclosed
EP-0947517-A1 CEPHEM DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 1999-10-06 EP disclosed